347 related articles for article (PubMed ID: 31342804)
21. Multiparametric-Magnetic Resonance/Ultrasound Fusion Targeted Prostate Biopsy Improves Agreement Between Biopsy and Radical Prostatectomy Gleason Score.
Porpiglia F; DE Luca S; Passera R; Manfredi M; Mele F; Bollito E; DE Pascale A; Cossu M; Aimar R; Veltri A
Anticancer Res; 2016 Sep; 36(9):4833-9. PubMed ID: 27630337
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy Specimens.
Harmon SA; Gesztes W; Young D; Mehralivand S; McKinney Y; Sanford T; Sackett J; Cullen J; Rosner IL; Srivastava S; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Dobi A; Sesterhenn IA; Turkbey B
Radiology; 2021 Jun; 299(3):613-623. PubMed ID: 33847515
[TBL] [Abstract][Full Text] [Related]
23. Persistent Discordance in Grade, Stage, and NCCN Risk Stratification in Men Undergoing Targeted Biopsy and Radical Prostatectomy.
Alshak MN; Patel N; Gross MD; Margolis D; Hu JC
Urology; 2020 Jan; 135():117-123. PubMed ID: 31568795
[TBL] [Abstract][Full Text] [Related]
24. The association between perineural invasion in mpMRI-targeted and/or systematic prostate biopsy and adverse pathological outcomes in robot-assisted radical prostatectomy.
Karsiyakali N; Bulent Ozgen M; Ozveren B; Akbal C; Dincer A; Durak H; Turkeri L
Actas Urol Esp (Engl Ed); 2022; 46(6):377-384. PubMed ID: 35260369
[TBL] [Abstract][Full Text] [Related]
25. Added Value of Concomitant Systematic and Fusion Targeted Biopsies for Grade Group Prediction Based on Radical Prostatectomy Final Pathology on Positive Magnetic Resonance Imaging.
Ploussard G; Beauval JB; Lesourd M; Almeras C; Assoun J; Aziza R; Gautier JR; Loison G; Portalez D; Salin A; Tollon C; Soulié M; Malavaud B; Roumiguié M
J Urol; 2019 Dec; 202(6):1182-1187. PubMed ID: 31246548
[TBL] [Abstract][Full Text] [Related]
26. A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.
Mehralivand S; Shih JH; Harmon S; Smith C; Bloom J; Czarniecki M; Gold S; Hale G; Rayn K; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
Radiology; 2019 Mar; 290(3):709-719. PubMed ID: 30667329
[TBL] [Abstract][Full Text] [Related]
27. More Favorable Pathological Outcomes in Men with Low Risk Prostate Cancer Diagnosed on Repeat versus Initial Transrectal Ultrasound Guided Prostate Biopsy.
ElShafei A; Nyame Y; Kara O; Badawy A; Amujiogu I; Fareed K; Klein E; Jones JS
J Urol; 2016 Jun; 195(6):1767-72. PubMed ID: 26724397
[TBL] [Abstract][Full Text] [Related]
28. Comparison of complications rates between multiparametric magnetic resonance imaging-transrectal ultrasound (TRUS) fusion and systematic TRUS prostatic biopsies.
Queiroz MRG; Falsarella PM; Mariotti GC; Lemos GC; Baroni RH; Mussi TC; Garcia RG
Abdom Radiol (NY); 2019 Feb; 44(2):732-738. PubMed ID: 30255444
[TBL] [Abstract][Full Text] [Related]
29. The Role of Magnetic Resonance Image Guided Prostate Biopsy in Stratifying Men for Risk of Extracapsular Extension at Radical Prostatectomy.
Raskolnikov D; George AK; Rais-Bahrami S; Turkbey B; Siddiqui MM; Shakir NA; Okoro C; Rothwax JT; Walton-Diaz A; Sankineni S; Su D; Stamatakis L; Merino MJ; Choyke PL; Wood BJ; Pinto PA
J Urol; 2015 Jul; 194(1):105-111. PubMed ID: 25623751
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the Upgrading Rates of International Society of Urological Pathology Grades and Tumor Laterality in Patients Undergoing Standard 12-Core Prostate Biopsy versus Fusion Prostate Biopsy for Prostate Cancer.
Demirtaş A; Sönmez G; Tombul ŞT; Demirtaş T; Akgün H
Urol Int; 2019; 103(3):256-261. PubMed ID: 31242496
[TBL] [Abstract][Full Text] [Related]
31. Incidental Prostate Adenocarcinoma in Cystoprostatectomy Specimens: Partial Versus Complete Prostate Sampling.
Filter ER; Gabril MY; Gomez JA; Wang PZT; Chin JL; Izawa J; Moussa M
Int J Surg Pathol; 2017 Aug; 25(5):414-420. PubMed ID: 28381150
[TBL] [Abstract][Full Text] [Related]
32. The role of transrectal ultrasound-guided staging biopsy and androgen ablation therapy prior to radical prostatectomy.
Lee F; Siders DB; Newby JE; McHugh TA; Solomon MH
Clin Invest Med; 1993 Dec; 16(6):458-70. PubMed ID: 8013152
[TBL] [Abstract][Full Text] [Related]
33. Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer.
Choi YH; Yu JW; Kang MY; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
World J Urol; 2019 Oct; 37(10):2129-2135. PubMed ID: 30603783
[TBL] [Abstract][Full Text] [Related]
34. Prostate volume measurement by multiparametric magnetic resonance and transrectal ultrasound: comparison with surgical specimen weight.
Martins T; Mussi TC; Baroni RH
Einstein (Sao Paulo); 2020; 18():eAO4662. PubMed ID: 32022105
[TBL] [Abstract][Full Text] [Related]
35. Can Extraprostatic Extension Be Predicted by Tumor-Capsule Contact Length in Prostate Cancer? Relationship With International Society of Urological Pathology Grade Groups.
Bakir B; Onay A; Vural M; Armutlu A; Yıldız SÖ; Esen T
AJR Am J Roentgenol; 2020 Mar; 214(3):588-596. PubMed ID: 31670596
[No Abstract] [Full Text] [Related]
36. Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted Biopsies.
Leyh-Bannurah SR; Kachanov M; Beyersdorff D; Preisser F; Tilki D; Fisch M; Graefen M; Budäus L
J Urol; 2018 Nov; 200(5):1035-1040. PubMed ID: 29935274
[TBL] [Abstract][Full Text] [Related]
37. Less qualitative multiparametric magnetic resonance imaging in prostate cancer can underestimate extraprostatic extension in higher grade tumors.
Schmit S; Allu S; Tanzer JR; Ortiz R; Pareek G; Hyams E
Int Braz J Urol; 2024; 50(1):37-45. PubMed ID: 38166221
[TBL] [Abstract][Full Text] [Related]
38. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
[TBL] [Abstract][Full Text] [Related]
39. Defining the optimal method for reporting prostate cancer grade and tumor extent on magnetic resonance/ultrasound fusion-targeted biopsies.
Gordetsky JB; Schultz L; Porter KK; Nix JW; Thomas JV; Del Carmen Rodriguez Pena M; Rais-Bahrami S
Hum Pathol; 2018 Jun; 76():68-75. PubMed ID: 29551676
[TBL] [Abstract][Full Text] [Related]
40. An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate Cancer.
Martini A; Soeterik TFW; Haverdings H; Rahota RG; Checcucci E; De Cillis S; Hermanns T; Fankhauser CD; Afferi L; Moschini M; Mattei A; Kesch C; Heidegger I; Preisser F; Zattoni F; Marquis A; Marra G; Gontero P; Briganti A; Montorsi F; Porpiglia F; Van Basten JP; Van den Bergh RCN; Van Melick HHE; Ploussard G; Gandaglia G; Valerio M
J Urol; 2022 Feb; 207(2):350-357. PubMed ID: 34547922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]